Literature DB >> 21763787

Should Alzheimer's disease be equated with human brain ageing? A maladaptive interaction between brain evolution and senescence.

David Neill1.   

Abstract

In this review Alzheimer's disease is seen as a maladaptive interaction between human brain evolution and senescence. It is predicted to occur in everyone although does not necessarily lead to dementia. The pathological process is initiated in relation to a senescence mediated functional down-regulation in the posteromedial cortex (Initiation Phase). This leads to a loss of glutamatergic excitatory input to layer II entorhinal cortex neurons. A human specific maladaptive neuroplastic response is initiated in these neurons leading to neuronal dysfunction, NFT formation and death. This leads to further loss of glutamatergic excitatory input and propagation of the maladaptive response along excitatory pathways linking evolutionary progressed vulnerable neurons (Propagation Phase). Eventually neurons are affected in many brain areas resulting in dementia. Possible therapeutic approaches include enhancing glutamatergic transmission. The theory may have implications with regards to how Alzheimer's disease is classified.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763787     DOI: 10.1016/j.arr.2011.06.004

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  8 in total

1.  The Roots of Alzheimer's Disease: Are High-Expanding Cortical Areas Preferentially Targeted?†.

Authors:  Anders M Fjell; Inge K Amlien; Markus H Sneve; Håkon Grydeland; Christian K Tamnes; Tristan A Chaplin; Marcello G P Rosa; Kristine B Walhovd
Journal:  Cereb Cortex       Date:  2014-03-21       Impact factor: 5.357

2.  Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease.

Authors:  Nicole C Berchtold; Paul D Coleman; David H Cribbs; Joseph Rogers; Daniel L Gillen; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2012-12-27       Impact factor: 4.673

Review 3.  What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

Authors:  Anders M Fjell; Linda McEvoy; Dominic Holland; Anders M Dale; Kristine B Walhovd
Journal:  Prog Neurobiol       Date:  2014-02-16       Impact factor: 11.685

Review 4.  Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?

Authors:  Alessandro Castorina; Marta Anna Szychlinska; Rubina Marzagalli; Giuseppe Musumeci
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

5.  Altered membrane properties but unchanged intrinsic excitability and spontaneous postsynaptic currents in an aged APP swe /PS1dE9 model of Alzheimer's disease.

Authors:  Shane M Ohline; Xinhuai Liu; Mohamed F Ibrahim; Bruce M Mockett; Ruth M Empson; Wickliffe C Abraham; Karl J Iremonger; Peter P Jones
Journal:  Front Cell Neurosci       Date:  2022-08-26       Impact factor: 6.147

6.  Body mass index related to executive function and hippocampal subregion volume in subjective cognitive decline.

Authors:  Ruilin Chen; Guiyan Cai; Shurui Xu; Qianqian Sun; Jia Luo; Yajun Wang; Ming Li; Hui Lin; Jiao Liu
Journal:  Front Aging Neurosci       Date:  2022-08-17       Impact factor: 5.702

7.  Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.

Authors:  Annie M Racine; Rebecca L Koscik; Christopher R Nicholas; Lindsay R Clark; Ozioma C Okonkwo; Jennifer M Oh; Ansel T Hillmer; Dhanabalan Murali; Todd E Barnhart; Tobey J Betthauser; Catherine L Gallagher; Howard A Rowley; N Maritza Dowling; Sanjay Asthana; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Cynthia M Carlsson; Bradley T Christian; Sterling C Johnson
Journal:  Alzheimers Dement (Amst)       Date:  2016

Review 8.  β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.

Authors:  Botond Penke; Ferenc Bogár; Lívia Fülöp
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.